Treatment of Nasopharyngeal Carcinoma: Therapeutic Management and Future View of Epstein-Barr Virus-Targeting Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1875-6301|5|3|170-177

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.5, Iss.3, 2009-08, pp. : 170-177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma

By Ambinder R.F.   Robertson K.D.   Moore S.M.   Yang J.  

Seminars in Cancer Biology, Vol. 7, Iss. 4, 1996-04 ,pp. : 217-226

Academic Press

Access to resources Recommend Favorite

Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinoma

By                        

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 2888-2894

Spandidos Publications

Access to resources Recommend Favorite

Involvement of the epstein-barr virus in the nasopharyngeal carcinoma pathogenesis

By Burgos Javier  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 113-121

Humana Press, Inc

Access to resources Recommend Favorite

Epstein-Barr virus and gastric carcinoma

By Osato T.   Imai S.  

Seminars in Cancer Biology, Vol. 7, Iss. 4, 1996-04 ,pp. : 175-182

Academic Press

Access to resources Recommend Favorite

CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients

By Lin Xiaorong   Gudgeon Nancy   Hui Edwin   Jia Hui   Qun Xue   Taylor Graham   Barnardo Martin   Lin C.   Rickinson Alan   Chan Anthony  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 7, 2008-07 ,pp. : 963-975

Springer Publishing Company

Access to resources Recommend Favorite